Sonya Kenkare, MD, FAAD

home / authors / sonya-kenkare-md-faad

Sonya Kenkare, MD, FAAD, is a board certified dermatologist in Hinsdale, Illinois

Articles

Utilizing Multidisciplinary Solutions for Itch

Utilizing Multidisciplinary Solutions for Itch

Sonya Kenkare, MD, FAAD
April 19th 2024

Sonya Kenkare, MD, explains her approach to itch and the support system of multiple specialties to help a pediatric patient with atopic dermatitis.

Comparing the Landscape of Topicals

Comparing the Landscape of Topicals

Sonya Kenkare, MD, FAAD
April 19th 2024

Sonya Kenkare, MD, details where ruxolitinib fits within the current landscape of pediatric atopic dermatitis treatments.

Dermatologist Shares Tips for Attending Annual Meeting

Dermatologist Shares Tips for Attending Annual Meeting

Sonya Kenkare, MD, FAAD;Heidi Anne Duerr, MPH
March 8th 2024

Dermatology Times chatted with Sonya Kenkare, MD, FAAD, for tips on navigating the annual meeting.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
Published: December 16th 2024 | Updated: December 18th 2024
The Burden of Prurigo Nodularis
ICYMI: FDA Approves Galderma's Nemolizumab for Moderate to Severe Atopic Dermatitis in Patients 12 and Older
Published: December 16th 2024 | Updated: December 18th 2024
ICYMI: FDA Approves Galderma's Nemolizumab for Moderate to Severe Atopic Dermatitis in Patients 12 and Older
FDA Approves Tapinarof Cream, 1% for Atopic Dermatitis in Patients 2 Years and Older
Published: December 16th 2024 | Updated: December 18th 2024
FDA Approves Tapinarof Cream, 1% for Atopic Dermatitis in Patients 2 Years and Older
Arcutis Submits sNDA for Roflumilast Cream 0.05% to FDA for Patients Ages 2 to 5 with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 18th 2024
Arcutis Submits sNDA for Roflumilast Cream 0.05% to FDA for Patients Ages 2 to 5 with Atopic Dermatitis
2024 Key Insights: Psoriasis
Published: December 13th 2024 | Updated: December 18th 2024
2024 Key Insights: Psoriasis
© 2024 MJH Life Sciences

All rights reserved.